Format

Send to

Choose Destination
Hematol Oncol Clin North Am. 1996 Apr;10(2):499-530.

Hypercoagulability in cancer.

Author information

1
Division of Hematology-Oncology, Cornell University Medical College, New York, USA.

Abstract

The association of cancer with a hypercoagulable state is documented by numerous clinical, biochemical, pathologic, and pharmacologic studies. This association is manifested clinically by an increased incidence of intravascular thrombotic events in cancer patients and by fibrin deposition in and around tumor beds. Thromboembolic disease is a major cause of morbidity and mortality in patients with malignancy. This article discusses the complex pathogenesis of this problem and the associated laboratory and clinical syndromes with recommendations on diagnosis and treatment.

PMID:
8707766
DOI:
10.1016/s0889-8588(05)70349-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center